|
TARSL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.560300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.621700E-02 |
| Normal-vs-Stage2 |
2.709400E-01 |
| Normal-vs-Stage3 |
4.354800E-01 |
| Normal-vs-Stage4 |
1.601410E-01 |
| Stage1-vs-Stage2 |
8.211000E-01 |
| Stage1-vs-Stage3 |
7.248200E-01 |
| Stage1-vs-Stage4 |
4.576800E-01 |
| Stage2-vs-Stage3 |
8.177400E-01 |
| Stage2-vs-Stage4 |
6.454000E-01 |
| Stage3-vs-Stage4 |
9.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.822000E-03 |
| Normal-vs-AfricanAmerican |
2.156200E-01 |
| Normal-vs-Asian |
6.983000E-01 |
| Caucasian-vs-AfricanAmerican |
3.672200E-01 |
| Caucasian-vs-Asian |
7.848800E-01 |
| AfricanAmerican-vs-Asian |
9.916400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.994600E-01 |
| Normal-vs-Female |
7.564300E-04 |
| Male-vs-Female |
2.503700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.697700E-02 |
| Normal-vs-Extreme_Weight |
1.683450E-01 |
| Normal-vs-Obese |
1.517450E-01 |
| Normal-vs-Extreme_Obese |
3.460800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.279400E-01 |
| Normal_Weight-vs-Obese |
2.949200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.259200E-01 |
| Extreme_Weight-vs-Obese |
7.756000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.633400E-01 |
| Obese-vs-Extreme_Obese |
9.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.960400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.560070E-02 |
| Normal-vs-Age(61-80Yrs) |
5.937600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.013820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.774800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.625000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.187980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.137200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.528600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.580300E-03 |
| Normal-VS-Type2 PRCC |
9.906500E-02 |
| Normal-VS-KIRP CIMP |
1.757360E-03 |
| Normal-VS-Unclassified PRCC |
1.039000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.090200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.560900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.997200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.896660E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.569800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.841770E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.155400E-01 |
| Normal-vs-N1 |
2.373400E-01 |
| Normal-vs-N2 |
8.038400E-01 |
| N0-vs-N1 |
2.540600E-01 |
| N0-vs-N2 |
7.436200E-01 |
| N1-vs-N2 |
7.187600E-01 |
|
|
